SNWV · SANUWAVE Health, Inc.

Track SNWV — free

$4.10 +0.10 (+2.50%) At close · Sep 11

Rebalance outlook locked

Market Cap

$35.27M

8.60M

Up next

Next earnings call

Dec 22, 2026 Est · unconfirmed · in 14 wks

Latest filing: 10-Q

filed Aug 6, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

View all 115 metrics

Revenue (TTM)

$44.02M

Trailing 12 months

Net income (TTM)

$15.26M

Trailing 12 months

Revenue growth YoY

-3.1%

Year over year

Operating margin

3.4%

Trailing 12 months

P / E (TTM)

4.5

Trailing earnings · reciprocal yield 22.4%

FCF yield

12.0%

TTM · current market cap

Return on invested capital

—

Trailing 12 months

Net cash

—

Latest balance sheet

Dividend yield

—

Trailing 12 months

Shares change YoY

-6.2%

Year over year · fewer shares

Price change (1Y)

-88.9%

Trailing year

Short interest

3.4%

Latest settlement · 4.7 days to cover

View all 115 metrics

Equibles Rating

blended score · not investment advice

Overall

Sell

SellHoldBuy

Technical Sell Momentum Very Weak Sentiment Neutral Fundamentals Excellent Quant / Vol Very High

Market backdrop VIX 15.8 · calm Equity put/call 0.58

Technical

price trend

Sell

50 / 200-day cross No cross

Price vs 200-day avg −77%

below

Price vs 50-day avg −35%

below

RSI (14) 28

oversold

MACD trend Positive

52-week position 0%

near low

Momentum

relative strength

Very Weak

1-month return −14%

trailing

6-month return −80%

trailing

YTD return −86%

this year

Relative strength −98%

vs S&P · 6-mo

Sentiment

smart money

Neutral

Trend (MA cross) No cross

50d $6 › 200d $18 — 200d above 50d

Institutional flow Distributing

-22% holders QoQ · +11 funds added

Insider flow Flat

No net insider activity over 90 days

Short interest Falling

3.39% of float · ▼ -4.3% MoM · 4.7 days cover

Volume signal Normal

Volume near normal

Institution breadth Steady

49 holders — mid 4-yr range

Squeeze score 49

elevated · 0–100

Fundamentals

Excellent

Revenue growth +35%

Y/Y

Gross margin 77%

expanding

EPS growth +106%

Y/Y

Free cash flow $1.9M

Balance sheet $9.9M

net debt

Quant / Vol

risk profile

Very High

Volatility 91%

annualized · 1-yr

Max drawdown −90%

past year

ATR 8.9%

of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

what management promised — and delivered

Latest guidance · from the 8-K filed May 12, 2026

Revenue · full year 2026 Initiated $51M – $55M

prior FY $44.05M midpoint +20.3% Y/Y

Prior guidance period ended · from the 8-K filed May 12, 2026

Revenue · Q2 2026 $11.1M – $11.6M

Guided vs delivered · last 1 settled

Revenue Q2 2026

guided $11.1M – $11.6M

guided $11.1M – $11.6M $9.74M Miss −14.2%

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Sell

3 · 2 · 1

50 / 200-day cross

No cross Neutral

Price vs 200-day avg

−77% Bearish

Price vs 50-day avg

−35% Bearish

RSI (14)

28 Neutral

MACD trend

Positive Bullish

52-week position

0% Bearish

Market signals — smart money & positioning

Mixed

Trend (MA cross) No cross

50d $6 › 200d $18 — 200d above 50d

Institutional flow Distributing

-22% holders QoQ · +11 funds added

Insider flow Flat

No net insider activity over 90 days

Short interest Falling

3.39% of float · ▼ -4.3% MoM · 4.7 days cover

Volume signal Normal

Volume near normal

Institution breadth Steady

49 holders — mid 4-yr range

Price context

position in its 52-week range

Range low $4 Now $4 · 0% Range high $41

vs 200-day avg -77% vs 50-day avg -35%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.

Versus peers

Medical Devices — same industry group

Open screener →

Company	Mkt cap	YTD	Rev growth Y/Y	P/E	Short % shares
SNWV SANUWAVE Health, Inc. this stock	$35.27M	-86.3%	+35.0%	—	3.4%
ABT Abbott Laboratories	$177.58B	-18.6%	+5.7%	28.6	1.3%
MDT Medtronic plc	$116.35B	-5.3%	+8.4%	22.4	0.9%
SYK Stryker Corp	$105.70B	-21.6%	+11.2%	28.6	2.0%
BSX Boston Scientific Corp	$62.29B	-54.9%	+12.5%	17.4	3.3%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section

Ownership

Institutional Holders Reducing

Holders

% held: 37.3%
Net QoQ: -954.5K sh
Top holder: Solas Capital Management,…

Held Float

View

Held by Funds

Fund positions

View

Short & Settlement

Short Interest Falling

Shares short

291.4K

Days to cover: 4.7d
Change: -13.2K sh

View

Short Volume

Short vol %

58%

As of: Sep 11, 2026

Short Total

View

Fails to Deliver

FTD shares

Value: $339
As of: Jul 13, 2026

View

Off-Exchange

Off-exchange %

54.6%

Week of: Aug 3, 2026

Off-exch Lit

View

Financials

Revenue (FY)

$44.1M

Net income (FY): $11.8M
EPS diluted: $0.41

View

Filings

SEC Filings

Latest

8-K

Filed: Aug 6, 2026
This year: 13

View

Proposed Sales

Value

$5.1M

Shares: 155.4K
Filed: Jun 25, 2025

View

Exempt Offerings

Offering

$1.8M

Filed: Jul 2, 2024

View

Earnings & Events

Earnings Calls

Last call

Aug 7, 2026

View

Performance

	5D	20D	120D	MTD	YTD
SNWV	-7.9%	-14.1%	-79.7%	-12.6%	-86.3%
SPY	-1.2%	-1.8%	+17.8%	-0.4%	+12.1%
vs SPY	-6.7%	-12.3%	-97.5%	-12.2%	-98.3%

Key facts CIK 1417663 CUSIP 80303D305 13F (30d) 19 filings 19 filers Visit website Investor relations

SNWV · SANUWAVE Health, Inc.

Price & Indicators

Up next

Metrics snapshot

Equibles Rating

Guidance & track record

Technicals

Key metrics

Versus peers

At a glance

Performance